Kai Wu
About Kai Wu
Kai Wu is a Manager of Clinical Programming at BeiGene in San Mateo, California, with extensive experience in drug development, molecular biology, biochemistry, bioinformatics, and clinical trials.
Current Role at BeiGene
Kai Wu currently holds the position of Manager, Clinical Programming at BeiGene in San Mateo, California. Kai began working at BeiGene in November 2018 and has been contributing to the company's clinical programming efforts since then. His extensive background in bioinformatics and clinical trials supports his role in managing clinical data and programming activities that are crucial to the development and approval of new therapies.
Previous Experience at Gilead Sciences
Prior to his current role at BeiGene, Kai Wu worked at Gilead Sciences for an impressive 15 years, from 2003 to 2018. Initially joining the company as a contractor for four months in 2003, he transitioned to the role of Manager, Clinical Programming. During his tenure, Kai played a key role in the clinical programming department, contributing to both early and late stages of drug development. His long-term commitment and contributions were vital to the success of numerous clinical trials.
Educational Background
Kai Wu's educational journey is marked by a strong foundation in genetics and biochemistry. He earned a BS in Genetics from Fudan University, studied Human Genetics at Peking Union Medical College, and completed a Ph.D. in Biochemistry from the University of Miami Miller School of Medicine. Additionally, Kai undertook a Postdoctoral fellowship at the University of Georgia, College of Veterinary Medicine, further honing his expertise in the field.
Early Career and Bioinformatics
Kai Wu's early career was focused on the field of bioinformatics and molecular biology. From 2000 to 2001, he worked as a Bioinformatics Scientist at doubletwist, followed by a similar role at LumiCyte from 2001 to 2003. His career began even earlier as a Scientist at Kosan from 1998 to 2000 and as a Postdoctoral Fellow at Genentech from 1995 to 1998. These roles allowed him to build a solid foundation in molecular biology, biochemistry, and bioinformatics, which have been crucial to his contributions in drug development and clinical trials.
Specializations and Expertise
Kai Wu specializes in molecular biology, biochemistry, bioinformatics, and clinical trials. His extensive experience encompasses both the early and late stages of drug development, providing him with a comprehensive understanding of the clinical programming landscape. His expertise includes managing clinical data, developing programming solutions, and overseeing the successful execution of clinical trials, all of which contribute to advancing therapeutic developments.